Lyon, France, May 4, 2022 – Raul Nogueira, MD, department endowed professor, division chief of cerebrovascular medicine and director of the UPMC Stroke Institute, presented favorable results of the study Endovascular treatment for acute basilar artery occlusion: A multicenter randomized controlled trial (ATTENTION) at the 2022 European Stroke Organisation Conference (ESOC) in Lyon, France. Dr. Nogueira is the Principal Investigator for this clinical trial.
The ATTENTION Study addressed the research question, “Stroke caused by a blockage in the basilar artery can be extremely devastating to the patient. Can endovascular treatment (EVT), also known as clot retrieval, improve the outcome of these patients?” Investigators recruited patients from 36 comprehensive stroke centers in China between February 2021 and January 2022; all patients were adults that presented with a blockage in the basilar artery confirmed with vascular imaging with 12 hours of stroke onset. The 3-month patient flow outline is shown below.
Overall, 340 patients (226 EVT and 114 BMM [best medical management]) were included in the final analysis. The primary outcome suggested that since there was a lower mortality rate in the EVT group, endovascular treatment not only reduced disability but also death.
To learn more about the results of the ATTENTION Study, please click here.